基于转录组学方法和网络药理学的Erianin抗三阴性乳腺癌的机制
Ming Li1, Yuan Zhao2, Huimin Li1
1Laboratory of Molecular Genetics of Aging and Tumour, Medical School, Kunming University of Science and Technology, Chenggong Campus, Kunming, Yunnan 650500, China.
Aging
|February 8, 2024
概括
埃里安宁通过降低PI3K/AKT信号通路的调节,有效地抑制三阴性乳腺癌 (TNBC) 的扩散和瘤生长,提供了一个有前途的新治疗途径.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 生物信息学是一种生物信息学.
背景情况:
- 三阴性乳腺癌 (TNBC) 是一种缺乏向治疗的侵袭性癌症亚型.
- 埃里安宁表现出潜在的抗瘤活性,但其在TNBC中的机制尚未完全理解.
研究的目的:
- 通过转录组学和网络药理学阐明Erianin在TNBC中的作用机制.
- 为了确定关键的分子标和途径受影响的Erianin在TNBC.
主要方法:
- 转录学和网络药理学被用来识别Erianin的目标.
- 试验室TNBC细胞系和体内异种移植模型用于生物活性评估.
- 进行了分子对接和西部斑分析以验证目标和途径.
主要成果:
- 埃里亚宁显著抑制了TNBC细胞增殖和瘤生长.
- 确定了51个共同目标,突出了8个中心目标,包括PPARA和ROCK2.
- 埃里安宁被发现可以抑制PI3K/Akt信号通路,这一点得到了西方布洛特和SC79共同化实验的证实.
结论:
- 埃里亚宁通过抑制瘤增殖和瘤生长来证明TNBC的治疗潜力.
- PI3K/AKT信号通路是Erianin抗TNBC作用的关键调解者.
- 埃里安宁代表了新型TNBC药物开发的有希望的候选人.
相关概念视频
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Transducer Mechanism: Nuclear Receptors
1.3K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.3K
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.2K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K


